Maciej Krzakowski
- Oncology top 0.1%
- Lung Cancer Research Studies 69
- Colorectal Cancer Treatments and Studies 27
- Cancer Treatment and Pharmacology 23
- Pulmonary and Respiratory Medicine top 0.1%
- Lung Cancer Treatments and Mutations 128
- Lung Cancer Diagnosis and Treatment 57
- Cancer Research top 1%
- Cancer Genomics and Diagnostics 17
- Hematology top 1%
- Hepatology top 2%
-
- Multiple and Secondary Primary Cancers 19
- Neuroendocrine Tumor Research Advances 16
Maciej Krzakowski
233 papers receiving 11.0k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Oncology 7.6k
- Pulmonary and Respiratory Medicine 6.4k
- Cancer Research 1.6k
- Hematology 851
- Hepatology 426
Countries citing papers authored by Maciej Krzakowski
This map shows the geographic impact of Maciej Krzakowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maciej Krzakowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maciej Krzakowski more than expected).
Fields of papers citing papers by Maciej Krzakowski
This network shows the impact of papers produced by Maciej Krzakowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maciej Krzakowski. The network helps show where Maciej Krzakowski may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Maciej Krzakowski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 1 | |
| 10 | 2022 | 4 | |
| 11 | 2022 | 7 | |
| 12 | 2022 | 5 | |
| 13 | 2021 | 12 | |
| 14 | 2020 | 2 | |
| 15 | Guidelines for the prevention and treatment of venous thromboembolism in patients with cancers treated conservatively | 2016 | 6 |
| 16 | Recommendations on the application of positron emission tomography in oncology | 2015 | 1 |
| 17 | 2015 | 3 | |
| 18 | EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX studybreakdown → | 2011 | 453 |
| 19 | Epidermal growth factor receptor (EGFR) inhibition on non-small-cell lung cancer treatment | 2011 | 1 |
| 20 | Postępy w zakresie systemowego leczenia raka jelita grubego w stadium zaawansowanym | 2005 | 0 |
About Maciej Krzakowski
Maciej Krzakowski is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Epidemiology and Internal Medicine, having authored 261 papers that have together received 11.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (128 papers), Lung Cancer Research Studies (69 papers), Lung Cancer Diagnosis and Treatment (57 papers), Colorectal Cancer Treatments and Studies (27 papers), Cancer Treatment and Pharmacology (23 papers), Multiple and Secondary Primary Cancers (19 papers), Cancer Genomics and Diagnostics (17 papers) and Neuroendocrine Tumor Research Advances (16 papers). The work is most often cited by research in Oncology (7.6k citations), Pulmonary and Respiratory Medicine (6.4k citations), Cancer Research (1.6k citations), Hematology (851 citations) and Hepatology (426 citations). Maciej Krzakowski has collaborated with scholars based in Poland, Germany and France. Frequent co-authors include Joachim von Pawel, Rodryg Ramlau, Keunchil Park, Filippo de Marinis, Vera Hirsh, Robert Pirker, Aleksandra Szczęsna, Kenneth J. O’Byrne, Wilfried Eberhardt and Jose R. Pereira. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, Annals of Oncology, Journal of Thoracic Oncology and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.